Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ:MLTX)

13.80 +0.19 (+1.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,423,441
Open	13.61
Bid (Size)	13.76 (100)
Ask (Size)	13.80 (100)
Prev. Close	13.61
Today's Range	13.37 - 13.99
52wk Range	5.950 - 62.75
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MLTX Class Action Reminder – Robbins LLP Reminds MoonLake Immunotherapeutics Stockholders of the Opportunity to Lead the Class Action Lawsuit

November 25, 2025

From Robbins LLP

Via GlobeNewswire

Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics (MLTX)

November 25, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	-74.2%	-74.2%
1 Month	+37.0%	+37.0%
3 Month	-75.1%	-75.1%
6 Month	-63.8%	-63.8%
1 Year	-73.9%	-73.9%

More News

Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics (MLTX)

November 25, 2025

Via TheNewswire.com

Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines

November 24, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

November 24, 2025

From Schall Law

Via GlobeNewswire

Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & Korsinsky

November 24, 2025

Via TheNewswire.com

Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & Korsinsky

November 24, 2025

Via NewMediaWire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

November 24, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

November 22, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX

November 21, 2025

Via TheNewswire.com

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX

November 21, 2025

Via NewMediaWire

MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

November 20, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

November 20, 2025

From Schall Law

Via GlobeNewswire

MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX

November 20, 2025

Via NewMediaWire

MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX

November 20, 2025

Via TheNewswire.com

MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX

November 19, 2025

Via NewMediaWire

MoonLake Immunotherapeutics Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX

November 19, 2025

Via TheNewswire.com

MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline

November 18, 2025

Via TheNewswire.com

MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline

November 18, 2025

Via NewMediaWire

5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗

November 18, 2025

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Stockholders of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights Before Upcoming Deadlines

November 17, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

November 17, 2025

From Schall Law

Via GlobeNewswire

Levi & Korsinsky Notifies Shareholders of MoonLake Immunotherapeutics (MLTX) of a Class Action Lawsuit and an Upcoming Deadline

November 17, 2025

Via TheNewswire.com

Levi & Korsinsky Notifies Shareholders of MoonLake Immunotherapeutics (MLTX) of a Class Action Lawsuit and an Upcoming Deadline

November 17, 2025

Via NewMediaWire

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

November 17, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Frequently Asked Questions

Is MoonLake Immunotherapeutics - Class A Ordinary Shares publicly traded?

Yes, MoonLake Immunotherapeutics - Class A Ordinary Shares is publicly traded.

What exchange does MoonLake Immunotherapeutics - Class A Ordinary Shares trade on?

MoonLake Immunotherapeutics - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for MoonLake Immunotherapeutics - Class A Ordinary Shares?

The ticker symbol for MoonLake Immunotherapeutics - Class A Ordinary Shares is MLTX on the Nasdaq Stock Market

What is the current price of MoonLake Immunotherapeutics - Class A Ordinary Shares?

The current price of MoonLake Immunotherapeutics - Class A Ordinary Shares is 13.80

When was MoonLake Immunotherapeutics - Class A Ordinary Shares last traded?

The last trade of MoonLake Immunotherapeutics - Class A Ordinary Shares was at 11/26/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.